LAC Med targets Indonesia after steady debut on Main Market

From left: Hong Chong Chet, LAC Med deputy CEO; Goh Teck Hong, independent non-executive director; Giam Teck Eng, substantial shareholder; Kevin Davies, CEO, RHB Investment Bank Bhd; Liew Yoon Poh, LAC Med group CEO; Liew Yoon Kit, non-independent non-executive chairman; Teoh Chu Lin, Alliance Bank Malaysia Bhd group chief corporate and institutional banking officer, Chan Yue Mun, LAC Med non-independent non-executive director; Datuk Ng Wan Peng, senior independent non-executive director; Lim Su May, independent non-executive director; and Thean Yain Peng, chief financial officer

KUALA LUMPUR: LAC Med Bhd made a steady debut on the Main Market of Bursa Malaysia yesterday, opening unchanged at its initial public offering (IPO) price of 75 sen amid brisk early trading.

About 5.8 million shares changed hands in the first session, following strong demand during its IPO exercise.